Literature DB >> 34099577

Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential.

Ziqi Zhou1, Kenrie P Y Hui1, Ray T Y So2, Huibin Lv2, Ranawaka A P M Perera1, Daniel K W Chu1, Esayas Gelaye3, Harry Oyas4, Obadiah Njagi4, Takele Abayneh3, Wilson Kuria4, Elias Walelign5, Rinah Wanglia6, Ihab El Masry7, Sophie Von Dobschuetz7, Wantanee Kalpravidh7, Véronique Chevalier8,9, Eve Miguel10,11, Ouafaa Fassi-Fihri12, Amadou Trarore13, Weiwen Liang2, Yanqun Wang14, John M Nicholls15, Jincun Zhao14, Michael C W Chan1, Leo L M Poon1,2, Chris Ka Pun Mok16,17, Malik Peiris18,2.   

Abstract

Coronaviruses are pathogens of pandemic potential. Middle East respiratory syndrome coronavirus (MERS-CoV) causes a zoonotic respiratory disease of global public health concern, and dromedary camels are the only proven source of zoonotic infection. More than 70% of MERS-CoV-infected dromedaries are found in East, North, and West Africa, but zoonotic MERS disease is only reported from the Arabian Peninsula. We compared viral replication competence of clade A and B viruses from the Arabian Peninsula with genetically diverse clade C viruses found in East (Egypt, Kenya, and Ethiopia), North (Morocco), and West (Nigeria and Burkina Faso) Africa. Viruses from Africa had lower replication competence in ex vivo cultures of the human lung and in lungs of experimentally infected human-DPP4 (hDPP4) knockin mice. We used lentivirus pseudotypes expressing MERS-CoV spike from Saudi Arabian clade A prototype strain (EMC) or African clade C1.1 viruses and demonstrated that clade C1.1 spike was associated with reduced virus entry into the respiratory epithelial cell line Calu-3. Isogenic EMC viruses with spike protein from EMC or clade C1.1 generated by reverse genetics showed that the clade C1.1 spike was associated with reduced virus replication competence in Calu-3 cells in vitro, in ex vivo human bronchus, and in lungs of hDPP4 knockin mice in vivo. These findings may explain why zoonotic MERS disease has not been reported from Africa so far, despite exposure to and infection with MERS-CoV.
Copyright © 2021 the Author(s). Published by PNAS.

Entities:  

Keywords:  Africa; MERS-CoV; characterization; coronaviruses; phenotype

Year:  2021        PMID: 34099577     DOI: 10.1073/pnas.2103984118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  Why do some coronaviruses become pandemic threats when others do not?

Authors:  Benjamin L Rice; Justin Lessler; Clifton McKee; C Jessica E Metcalf
Journal:  PLoS Biol       Date:  2022-05-16       Impact factor: 9.593

2.  Beta interferons from the extant camelids: Unique among eutherian mammals.

Authors:  Avinash Premraj; Abi George Aleyas; Binita Nautiyal; Thaha Jamal Rasool
Journal:  Dev Comp Immunol       Date:  2022-05-12       Impact factor: 3.605

3.  SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.

Authors:  Kenrie P Y Hui; John C W Ho; Man-Chun Cheung; Ka-Chun Ng; Rachel H H Ching; Ka-Ling Lai; Tonia Tong Kam; Haogao Gu; Ko-Yung Sit; Michael K Y Hsin; Timmy W K Au; Leo L M Poon; Malik Peiris; John M Nicholls; Michael C W Chan
Journal:  Nature       Date:  2022-02-01       Impact factor: 49.962

Review 4.  Unresolved questions in the zoonotic transmission of MERS.

Authors:  Malik Peiris; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2022-01-06       Impact factor: 7.090

5.  Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.

Authors:  Darrell R Kapczynski; Ryan Sweeney; Erica Spackman; Mary Pantin-Jackwood; David L Suarez
Journal:  Virology       Date:  2022-02-12       Impact factor: 3.616

6.  Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas.

Authors:  Hang Chi; Yanqun Wang; Entao Li; Xiwen Wang; Hualei Wang; Hongli Jin; Qiuxue Han; Zhenshan Wang; Xinyue Wang; Airu Zhu; Jing Sun; Zhen Zhuang; Lu Zhang; Jingmeiqi Ye; Haijun Wang; Na Feng; Mingda Hu; Yuwei Gao; Jincun Zhao; Yongkun Zhao; Songtao Yang; Xianzhu Xia
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

7.  Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity.

Authors:  Khaled R Alkharsah; Salma Ali Aljaroodi; Jawad Ur Rahman; Awatif N Alnafie; Reem Al Dossary; Reem Y Aljindan; Amani M Alnimr; Jamal Hussen
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

8.  Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya.

Authors:  Isaac Ngere; Elizabeth A Hunsperger; Suxiang Tong; Julius Oyugi; Walter Jaoko; Jennifer L Harcourt; Natalie J Thornburg; Harry Oyas; Mathew Muturi; Eric M Osoro; John Gachohi; Cynthia Ombok; Jeanette Dawa; Ying Tao; Jing Zhang; Lydia Mwasi; Caroline Ochieng; Athman Mwatondo; Boku Bodha; Daniel Langat; Amy Herman-Roloff; M Kariuki Njenga; Marc-Alain Widdowson; Peninah M Munyua
Journal:  Viruses       Date:  2022-08-09       Impact factor: 5.818

9.  In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein.

Authors:  Raina Rhoades; Adebiyi Sobitan; Vidhyanand Mahase; Brhan Gebremedhin; Qiyi Tang; Danda Rawat; Hongbao Cao; Shaolei Teng
Journal:  Front Mol Biosci       Date:  2022-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.